Kidney failure, stroke, heart attack and death following open heart or bypass surgery have been caused by Trasylol®, a drug manufactured by the German pharmaceutical conglomerate, Bayer AG.
It was intended to limit bleeding during surgery procedures.
But in November 2007 Bayer AG was forced to pull Trasylol® from the market following a request by the FDA.





